Publication:
The efficacy of lacosamide in children with drug-resistant focal epilepsy

Placeholder

Organizational Units

Program

KU-Authors

KU Authors

Co-Authors

Yıldırım, Canan

Advisor

Publication Date

2021

Language

English

Type

Journal Article

Journal Title

Journal ISSN

Volume Title

Abstract

Introduction: This study aimed to assess the efficacy, tolerability and adverse effects of Lacosamide (LCM) in children with refractory focal epilepsy. Methods: Children aged younger than 16 years with drug-resistant focal epilepsy were enrolled. The medical records and seizure diaries that were evaluated every three months were reviewed. Response to LCM was defined as ≥50% reduction in seizure frequency. Results: Twenty-five children with drug-resistant focal epilepsy received LCM as add-on therapy. The mean duration of epilepsy was 5.2 years and the mean age at LCM initiation was 8 years. The rate of response to LCM treatment in the 3th, 6th and 9th months were 44%, 64%, 76%, respectively. At the end of 12 months, the response rate was 84% and 16% of the patients were seizure free. Four patients had adverse effects; three patients were discontinued LCM and one improved after decreasing the dose of the drug. Discussion and Conclusion: LCM is an effective add-on antiepileptic drug for children with refractory focal epilepsy. It diminishes the frequency of seizures over time. It is well tolerated and a promising option in these patients.

Description

Source:

Haydarpaşa Numune Medical Journal

Publisher:

Haydarpaşa Numune Training and Research Hospital

Keywords:

Subject

Children, Epilepsy, Çocuklar, Epilepsi

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

0

Views

0

Downloads

View PlumX Details